Results 141 to 150 of about 31,024 (202)

Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders. [PDF]

Neuroprotection
Kuan JH, Raghavan RS, Koh DLW, Tan WY, Iezhitsa I, Agarwal R.   +5 more
europepmc   +1 more source

Red yeast rice with monacolin K for the improvement of hyperlipidemia: A narrative review. [PDF]

World J Clin Cases
English K.
europepmc   +1 more source

Research Progress, Safety Regulation and Application Prospects in Health Food Development of Red Yeast Rice-Derived Bioactive Compounds: A Critical Narrative Review. [PDF]

Foods
Chen X, Zheng M, Chen Q, Wang S, Jia X, Shen W, Zhou M, Li D.   +7 more
europepmc   +1 more source

Case Report: Rapid and Effective Treatment of Porokeratosis With Fractional CO₂ Laser Combined With Topical 2% Cholesterol/Lovastatin Ointment. [PDF]

J Cosmet Dermatol
Gao P, Zhang X, Yang H, Wang J.
europepmc   +1 more source

Polyamine Induction of Secondary Metabolite Biosynthetic Genes in Fungi Is Mediated by Global Regulator LaeA and α-NAC Transcriptional Coactivator: Connection to Epigenetic Modification of Histones. [PDF]

Molecules
Martín JF.
europepmc   +1 more source

Statins regulate kinase signaling by causing changes in phosphorylation, rather than through changes in gene expression or direct inhibition: evidence in colorectal cancer. [PDF]

Front Pharmacol
Lagunas-Rangel FA, Jonsson J, Jackevica L, Fredriksson R, Dambrova M, Schiöth HB.   +5 more
europepmc   +1 more source

Assessments of CYP-Inhibition-Based Drug-Drug Interactions Between Tofacitinib and Lipid-Lowering Agents in Rats Both In Vitro and In Vivo. [PDF]

Pharmacol Res Perspect
Yang H, Wang S, Zhou Q, Geng P, Lu Z, Lin Q, Chen C, Zhou Y, Cai J, Dai D.   +9 more
europepmc   +1 more source

Computational and experimental exploration of statin and statin-like compounds as potential treatment of schistosomiasis. [PDF]

PLoS Negl Trop Dis
Paul-Odeniran KF, Odeniran PO, Häberli C, Keiser J, Laughton CA.   +4 more
europepmc   +1 more source

Natural products as HMG-CoA reductase inhibitors (statins) for the management of non-communicable diseases. [PDF]

Inflammopharmacology
Muhammad RN, Aborehab NM, Aly SH, Nasr NN, Hindam MO, Mustafa AM, Faheem SA, Fawzy MH, Abo-El Fetoh ME, El-Dessouki AM, Rabie MA, El-Shiekh RA, Youssef ME.   +12 more
europepmc   +1 more source